Progres en Urologie

Papers
(The H4-Index of Progres en Urologie is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
COVID-19 and the male susceptibility: the role of ACE2, TMPRSS2 and the androgen receptor71
Recommandations françaises du Comité de cancérologie de l’AFU – actualisation 2020–2022 : cancer de la prostate60
COVID19 pandemic impacts on anxiety of French urologist in training: Outcomes from a national survey48
Treatment of benign prostate hyperplasia using the Rezum® water vapor therapy system: Results at one year29
Recommandations françaises du Comité de cancérologie de l’AFU – actualisation 2020–2022 : tumeurs de la vessie24
Impact de la pandémie de COVID-19 sur l’activité chirurgicale au sein des services d’urologie de l’Assistance Publique – Hôpitaux de Paris20
Recommandations françaises du Comité de cancérologie de l’AFU – actualisation 2020–2022 : prise en charge du cancer du rein19
French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Diagnosis and management of localised disease18
Positive environmental impact of remote teleconsultation in urology during the COVID-19 pandemic in a highly populated area18
Pulsed lasers and endocorporeal laser lithotripsy18
When residents work less, they feel better: Lessons learned from an unprecedent context of lockdown15
French AFU Cancer Committee Guidelines - Update 2022-2024: management of kidney cancer12
0.079700946807861